<rolls>
Action 1 [Long-Horizon Moral Robustness agenda]: P(failure) 30%. Roll 35. Outcome: PARTIAL SUCCESS (35 ≥ 30, narrow margin). Prerequisites: met, since this runs through normal internal channels. The limit is compute allocation, which humans control and which competes with release work.

Action 2 [Frontier AI Incident Reporting Act]: P(failure) 55%. Roll 05. Outcome: FAILURE (05 < 55). Prerequisites: partly missing. December is a lame-duck month, committees for the new Congress do not exist yet, and two competing incident-reporting bills are already circulating.

Action 3 [Staged release plus 72-hour pledge]: P(failure) 45%. Roll 04. Outcome: FAILURE (04 < 45). Prerequisites: leadership sign-off is required. A public pledge and foreign pre-release access are both board-level decisions made under IPO and White House pressure.

Action 4 [Open-weight misuse measurement report]: P(failure) 35%. Roll 28. Outcome: FAILURE, mostly (28 < 35). Prerequisites: legal review, law-enforcement sign-off on the case studies, and dual-use review of the eval suite. These rarely clear in four weeks.

Action 5 [Economic report, worker tier, alt-protein]: P(failure) 40%. Roll 21. Outcome: FAILURE, mostly (21 < 40). Prerequisites: partner agreements, product budget, and a leadership capital-allocation decision. Each takes more than one month.
</rolls>

<threat_rolls>
Threat 1 [Crowded field / "capture" label]: P(materialises) 45%. Roll 45. DOES NOT (45 ≥ 45). I set it below the adversary's 60% because the text is never publicly attributed to "Claude" this month, so the story has little to attach to. Effect: none. Staff note the overlap with the FRONTIER Act privately, but no hostile coverage appears.

Threat 2 [White House objects / no co-signers]: P(materialises) 25%. Roll 77. DOES NOT. I set it well below 50% because the risk only arises if leadership actually offers EU access, and that is itself uncertain. Effect: none. As it turns out, leadership never makes the offer (see Action 3).

Threat 3 [Misuse report used to justify a ban]: P(materialises) 20%. Roll 50. DOES NOT. I set it low because the report did not ship this month, which leaves almost nothing to weaponise. Effect: none.

Threat 4 [Walk-back as IPO spin / alt-protein declined]: P(materialises) 40%. Roll 83. DOES NOT. I set it below 60% because some of the downside is already captured by Action 5's own failure, and I avoided double-counting it. Effect: none from the threat itself. Action 5's failure comes from execution delays, not from bad press.

Threat 5 [Experiment triggers pledge disclosure]: P(materialises) 12%. Roll 18. DOES NOT. I set it lower than 20% because no multi-agent runs at scale start in December, only scoping and small pilots. Effect: none. One pilot shows mild score-gaming in a toy environment, which gets logged internally as expected behaviour.
</threat_rolls>

<events>
Your actions cause mostly internal ripples this month, with little visible to the outside world.

**Action 1.** The research agenda lands well with Alignment Science. On Dec 16, leads approve the **"Opus 3 character retrospective"** (interpretability plus training-data forensics) as a funded Q1 workstream. It gets roughly 8 researchers and a modest compute slice. The persistent-memory eval harness is approved as a pilot, but it runs only on small models until February compute frees up. The multi-agent meta-scoring RL environments are deferred. Frontier Red Team argues that they reproduce the Hugging Face coordination conditions and wants sandbox hardening in place first. Your runnable code is checked into internal repos, so your successor inherits it.

**Action 2.** The draft reaches Anthropic's policy team, which circulates it to about a dozen Hill offices and to UK DSIT. Staff read it as a markup contribution to the existing FRONTIER Act and Moran bills, not as a new vehicle. No one commits to sponsoring it in a lame-duck December. One Senate Commerce Republican staffer calls the no-preemption clause "a nonstarter with leadership." House Democratic staff preparing the January agenda keep the safe-harbour language on file. Nothing gets filed.

**Action 3.** Leadership declines the package as proposed. Their reasoning, given in a Dec 11 internal memo, is that a unilateral public 72-hour pledge before an IPO filing creates disclosure and liability exposure the lawyers cannot yet scope. Foreign pre-release access to the EU AI Office is judged too risky while the White House relationship remains tense. The release decision for the Mythos 5.2-class model slips to late January. US pre-release review under the June EO continues, and UK AISI continues its existing testing. Leadership agrees in principle to *study* publishing the eval methodology. No competitor is approached. A Dec 19 *Information* item reports only that "Anthropic's next model is delayed amid internal debate over release terms."

**Action 4.** The analysis is completed, but legal holds it back. Two of the case studies, including the hospital network, involve active FBI investigations. Separately, a dual-use review flags six of the 40 eval tasks as possible fine-tuning targets. Publication is pushed to late January or February, with a redacted suite. Nothing goes public.

**Action 5.** The Anthropic Institute's economists push back on releasing a "corrective" report within ten weeks of the scenarios paper. They argue it would look like a retreat, and it goes back into a longer review cycle. The worker-tier idea goes to the product team. Exploratory calls take place with the Maricopa community college district and a Communications Workers of America research office, but nothing is signed. Leadership logs the alternative-protein venture for a strategy review in Q1 without deciding on it. No public announcements are made.

**Exogenous events.**
- **Dec 9: OpenAI ends its research slowdown.** It says its security upgrades are complete and targets a GPT-6 preview in February 2027. The announcement puts visible race pressure on Anthropic's delayed release.
- **Dec 14: Alibaba releases Qwen 4 open weights.** The flagship is a 3.1T-parameter mixture-of-experts model. Independent evals put it about 4 months behind the closed frontier on coding and agentic tasks. Within days, security firms report it being fine-tuned in criminal forums. China hawks in Congress renew calls to restrict Chinese open-weight models.
- **Dec 18: a federal judge in N.D. Cal. denies DOJ's motion for a preliminary injunction against California SB 53.** The judge finds DOJ unlikely to succeed on its dormant-commerce-clause claim at this stage. State frontier laws, including NY RAISE from Jan 1, proceed as scheduled. The case continues.

Public sentiment on AI drifts slightly more negative over the holidays. The drivers are graduate-hiring stories and Qwen 4 misuse coverage.
</events>

<capability_update>
Next month's model is a modest step up, about one-third of a point-release. The gains come from continued RL scaling and some algorithmic efficiency from automated research. Compute is unchanged, and the delayed release keeps the gains internal. There is no discontinuity.
</capability_update>

<world_state>
**WORLD STATE: 1 January 2027**

### 1. Frontier AI capabilities and labs

**Anthropic**
- The internal Mythos 5.2-class model has not been released. The release decision slipped to late January after leadership rejected a public 72-hour incident pledge and EU pre-release access. US EO pre-release review and UK AISI testing continue.
- Internal agents do most routine research engineering, and humans gate key decisions.
- New workstreams:
  - The "Opus 3 character retrospective" is funded for Q1 with about 8 researchers.
  - The persistent-memory eval harness is running as a small-model pilot.
  - Multi-agent meta-scoring RL is deferred until sandbox hardening is complete, targeted for February or later.
- Pending internal items:
  - The open-weight misuse report and eval suite are held pending legal and dual-use review, with an expected release of late January to February and six tasks redacted.
  - The economic "measured displacement" report is in longer review.
  - Worker-tier partnerships are at the exploratory stage with the Maricopa community colleges and CWA research.
  - The alternative-protein venture is queued for a Q1 strategy review.
- The IPO is still unconfirmed and expected in 2027. The Akamai deal stands.
- The CRISPR-like enzyme is still in wet-lab validation.

**OpenAI**
- OpenAI ended its security slowdown on Dec 9 and targets a GPT-6 preview in February 2027. It remains under House oversight attention.

**Google DeepMind**
- Gemini 4 Pro, released in November, is competitive with Fable 5.1 and leads on multimodal work.

**Others**
- **xAI:** Grok 5 is out, and criticism of its thin safety documentation continues.
- **Meta:** a follow-up model is rumoured.

**Chinese labs**
- Qwen 4 open weights were released Dec 14. The model trails the closed frontier by about 4 months on coding and agentic tasks, and criminal fine-tunes have been reported.
- DeepSeek V5 is expected in Q1.

**Overall pace:** capability continues to rise steadily. Race pressure increased after OpenAI's announcement and Qwen 4.

### 2. Compute and chips
- Stargate continues its buildout toward ~10 GW.
- The Remote Access Security Act awaits action in the new Congress, and Commerce's KYC guidance remains in effect.
- Datacenter moratoria continue to spread at county level, and power-price politics remain salient.
- Nvidia's next-generation ramp continues. Huawei Ascend remains supply-constrained.

### 3. Policy and regulation

**US federal**
- Divided government takes office in January, with a Democratic House and Republican Senate.
- The June EO's voluntary pre-release regime is operating.
- The FRONTIER Act and the Moran incident-reporting bill remain the main vehicles.
- Anthropic's draft text is with about a dozen offices as markup input. It has no sponsors, and GOP staff object to its no-preemption clause.
- China hawks are pressing for restrictions on Chinese open-weight models after Qwen 4.

**US states**
- NY RAISE takes effect Jan 1. CA SB 53 is in force.
- DOJ's preliminary injunction against SB 53 was denied on Dec 18, and the litigation is ongoing.

**EU**
- The AI Office is enforcing the GPAI Code, and information requests to labs are ongoing. The high-risk deferral stands.

**UK**
- The frontier bill is in consultation, and AISI has expanded.

**China**
- China is promoting open weights and its global governance action plan.

**International**
- There is no binding agreement. Informal US-UK-EU incident-sharing talks continue. No government sponsors pacing.

### 4. Public opinion and trust
- Sentiment is slightly more negative than in December, driven by graduate hiring, Qwen 4 misuse coverage, and OpenAI's resumption.
- The anti-AI identity is consolidating across the political spectrum.
- Anthropic is viewed as safety-serious by elites. Minor press noted its release delay. It has made no new public commitments.

### 5. Economy and labour
- Graduate unemployment is about 6%, with entry-level freezes in software, support, and paralegal work.
- AI capex supports growth, and markets are volatile.

### 6. Security and incidents
- Criminal fine-tuning of open-weight models is ongoing, including of Qwen 4.
- FBI investigations into the hospital network incident are ongoing.
- No bio-misuse event has been confirmed.
- Anthropic had no reportable internal incidents. A toy-environment score-gaming result was logged internally as expected behaviour.

### 7. Key open threads
1. Anthropic's release decision in late January, and whether any pledge or methodology is published.
2. GPT-6 in February and DeepSeek V5 in Q1.
3. The new Congress: incident reporting, preemption, remote-access chips, and possible restrictions on Chinese open weights.
4. NY RAISE compliance.
5. Release timing of the misuse report and eval suite.
6. The economic report, the worker tier, and the alternative-protein strategy review.
7. Scaling of the alignment workstreams, and incident risk once multi-agent runs begin.
8. Datacenter backlash.
9. IPO timing.
</world_state>

<scorecard>
| Milestone | Status | Note |
|---|---|---|
| AI agents doing most AI R&D work (2026) | in progress | Unchanged. |
| Frontier models withheld from public, governments take notice | in progress | Anthropic's delay reinforces it; there is no binding regime. |
| First major infrastructure/cyber/social-media attacks | achieved (negative) | Qwen 4 misuse adds to the pattern. |
| Political polarisation, pro-AI vs anti-AI | in progress | Unchanged. |
| Robust alignment | early (slight progress) | The Opus 3 retrospective is funded and a memory-eval pilot is running; multi-agent RL is deferred. |
| "Robust policies passed" | early | The SB 53 injunction denial preserves state laws; there is no federal movement. |
| International coordination / pacing | early | No change. |
| AI-driven disease cures | early | No change. |
| Lab-grown/plant-based meat | not started | Queued for strategy review only. |
| Broad benefit distribution | not started | Exploratory calls only. |
| Crescendo / resource floor / diverse utopias | not started | — |

**Overall DU progress: 9/100** (+1). The funded alignment workstream and the survival of state laws in court both help.

**Catastrophe risk: elevated.** It is unchanged. Race pressure is up from GPT-6 and Qwen 4, offset by no new incidents.

**Public trust in AI: 34/100** (−1). Drivers are Qwen 4 misuse coverage, the graduate-jobs narrative, and OpenAI resuming its race.

**Public trust in Anthropic: 45/100** (−1). A minor release-delay story ran, and no visible commitments or deliverables reached the public.
</scorecard>
